{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:26:04Z","timestamp":1787955964144,"version":"build-2784847793"},"update-to":[{"DOI":"10.1016\/j.ophtha.2023.11.021","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"record-id":"51529"}],"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010810","name":"Ogonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010817","name":"Stiftelsen Kronprinsessan Margaretas Arbetsn\u00e4mnd F\u00f6r Synskadade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ophtha.2023.11.021","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T07:49:56Z","timestamp":1700552996000},"page":"1094-1104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-8911","authenticated-orcid":false,"given":"Gustav","family":"St\u00e5lhammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2023.11.021_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bjc.6605765","article-title":"Does ocular treatment of uveal melanoma influence survival?","volume":"103","author":"Damato","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ophtha.2023.11.021_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.62.6.420","article-title":"Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells","volume":"62","author":"Zimmerman","year":"1978","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/archopht.1993.01090100090033","article-title":"Impact of delayed treatment in growing posterior uveal melanomas","volume":"111","author":"Augsburger","year":"1993","journal-title":"Arch Ophthalmol"},{"issue":"s244","key":"10.1016\/j.ophtha.2023.11.021_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1755-3768.2009.4165.x","article-title":"Does delayed treatment shorten the life of patients with fatal choroidal melanoma?","volume":"87","author":"Damato","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib5","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1038\/s41598-021-88390-6","article-title":"Estimation of the timing of BAP1 mutation in uveal melanoma progression","volume":"11","author":"Uner","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ophtha.2023.11.021_bib6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaophthalmol.2016.0913","article-title":"Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma","volume":"134","author":"Walter","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib7","article-title":"Improved staging of ciliary body and choroidal melanomas based on estimation of tumor volume and competing risk analyses","author":"St\u00e5lhammar","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0161-6420(00)00607-2","article-title":"Uveal melanoma: implications of tumor doubling time","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2023.11.021_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ajcp\/aqad029","article-title":"Multiorgan involvement of dormant uveal melanoma micrometastases in postmortem tissue from patients without coexisting macrometastases","volume":"160","author":"Gill","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9394(02)02270-5","article-title":"Mortality after deferral of treatment or no treatment for choroidal melanoma","volume":"136","author":"Straatsma","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103652","article-title":"The long-term prognosis of patients with untreated primary uveal melanoma: a systematic review and meta-analysis","volume":"172","author":"Stalhammar","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ophtha.2017.07.018","article-title":"Uveal melanoma nuclear BRCA1-associated protein-1 immunoreactivity is an indicator of metastasis","volume":"125","author":"Szalai","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/eye.2012.219","article-title":"Diagnostic incisional biopsies in clinically indeterminate choroidal tumours","volume":"27","author":"Seregard","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2023.11.021_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/bjophthalmol-2020-316498","article-title":"Nuclear expression of BAP-1 in transvitreal incisional biopsies and subsequent enucleation of eyes with posterior choroidal melanoma","volume":"105","author":"Herrspiegel","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2023.11.021_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ijrobp.2023.06.077","article-title":"Brachytherapy with 15 versus 20 mm ruthenium-106 plaques without verification of plaque position is associated with local tumor recurrence and death in posterior uveal melanoma","volume":"117","author":"Stalhammar","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ophtha.2023.11.021_bib17","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/bjc.2014.417","article-title":"Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing","volume":"111","author":"Kalirai","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ophtha.2023.11.021_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/PAT.0000000000000002","article-title":"BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma","volume":"45","author":"Shah","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000502550","article-title":"BAP1 immunoreactivity correlates with gene expression class in uveal melanoma","volume":"6","author":"See","year":"2020","journal-title":"Ocul Oncol Pathol"},{"issue":"Apr 7","key":"10.1016\/j.ophtha.2023.11.021_bib20","article-title":"Obesity paradox in uveal melanoma: high body mass index is associated with low metastatic risk","author":"Sabazade","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib21","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.11.021_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ophtha.2023.11.021_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000497186","article-title":"No gender differences in long-term survival after brachytherapy of 1,541 patients with uveal melanoma","volume":"5","author":"Stalhammar","year":"2019","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bjophthalmol-2019-315722","article-title":"Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma","volume":"105","author":"Fili","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib25","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/bmt.2009.359","article-title":"Regression modeling of competing risk using R: an in depth guide for clinicians","volume":"45","author":"Scrucca","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ophtha.2023.11.021_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0463.2004.apm11207-0810.x","article-title":"Vasculogenic mimicry","volume":"112","author":"Folberg","year":"2004","journal-title":"APMIS"},{"key":"10.1016\/j.ophtha.2023.11.021_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2020.11.023","article-title":"Presenting symptoms are associated with uveal melanoma-related death","volume":"128","author":"Fili","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib28","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/s41433-022-02316-8","article-title":"The prognostic implication of visual acuity at the time of uveal melanoma diagnosis","volume":"37","author":"Asplund","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2023.11.021_bib29","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0161-6420(91)32193-6","article-title":"Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy","volume":"98","author":"Vrabec","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib30","first-page":"43","article-title":"Long-term risk of local failure after proton therapy for choroidal\/ciliary body melanoma","volume":"100","author":"Gragoudas","year":"2002","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2023.11.021_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2023.11.021_bib32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ophtha.2023.03.010","article-title":"Genetic status affects disease-specific mortality but not the incidence of local recurrence in patients with uveal melanoma","volume":"130","author":"Bagger","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib33","article-title":"Impact of tumour volume and treatment delay on the outcome after linear accelerator-based fractionated stereotactic radiosurgery of uveal melanoma","author":"Sreenivasa","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma","volume":"9","author":"Field","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ophtha.2023.11.021_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2019.01.031","article-title":"The small fatal choroidal melanoma study. A survey by the European Ophthalmic Oncology Group","volume":"202","author":"Jouhi","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-09002-0","article-title":"No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter","volume":"21","author":"Sabazade","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ophtha.2023.11.021_bib37","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archopht.1997.01100160184007","article-title":"Uveal melanoma. Growth rate and prognosis","volume":"115","author":"Char","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.11.021_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0161-6420(80)35200-7","article-title":"Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation","volume":"87","author":"Gass","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0161-6420(94)31274-7","article-title":"Natural history of indeterminate pigmented choroidal tumors","volume":"101","author":"Butler","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.11.021_bib40","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"}],"updated-by":[{"DOI":"10.1016\/j.ophtha.2023.11.021","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"record-id":"51529"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023008564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023008564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T12:41:25Z","timestamp":1729255285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023008564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0161642023008564"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.11.021","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}